3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
3
Thoracic
2
Endocrine
2
Sarcoma
1
NET
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
183
Cisplatin
158
Radiotherapy
77
Carboplatin
71
Radiotherapy, Intensity-Modulated
70
Cetuximab
68
Magnetic Resonance Spectroscopy
65
Nivolumab
64
Paclitaxel
52
Docetaxel
50
Specimen Handling
45
Radiation
34
Gemcitabine
33
Fluorouracil
31
Surveys and Questionnaires
28
Biopsy
27
Drug Therapy
26
toripalimab
25
Platinum
25
Surgical Procedures, Operative
24
Standard of Care
23
1,2-diaminocyclohexaneplatinum II citrate
23
cemiplimab
22
Capecitabine
21
atezolizumab
20
Chemoradiotherapy
20
Ipilimumab
19
tislelizumab
18
durvalumab
18
Taxes
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radionuclide Imaging
×
Head & Neck
×
1 year
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled